Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Depreciation & Amortization (CF) (2016 - 2019)

Historic Depreciation & Amortization (CF) for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $490000.0.

  • Soleno Therapeutics' Depreciation & Amortization (CF) changed 0.0% to $490000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year decrease of 25.47%. This contributed to the annual value of $2.0 million for FY2024, which is 148.11% up from last year.
  • According to the latest figures from Q4 2019, Soleno Therapeutics' Depreciation & Amortization (CF) is $490000.0, which was down 0.0% from $490000.0 recorded in Q3 2019.
  • Soleno Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $582000.0 for Q4 2017, and its period low was -$44000.0 during Q3 2016.
  • Over the past 5 years, Soleno Therapeutics' median Depreciation & Amortization (CF) value was $455000.0 (recorded in 2017), while the average stood at $282944.9.
  • As far as peak fluctuations go, Soleno Therapeutics' Depreciation & Amortization (CF) crashed by 25714.29% in 2016, and later soared by 319371.82% in 2017.
  • Soleno Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $49228.0 in 2015, then tumbled by 64.11% to $17670.0 in 2016, then soared by 3193.72% to $582000.0 in 2017, then decreased by 15.81% to $490000.0 in 2018, then changed by 0.0% to $490000.0 in 2019.
  • Its Depreciation & Amortization (CF) was $490000.0 in Q4 2019, compared to $490000.0 in Q3 2019 and $489000.0 in Q2 2019.